Literature DB >> 15136761

The role of Cdx proteins in intestinal development and cancer.

Rong-Jun Guo1, Eun Ran Suh, John P Lynch.   

Abstract

Since their original identification in Drosophila, the caudal related homologues (Cdx1 and Cdx2) have been known to be evolutionarily conserved both in molecular structure and function. In a great variety of organisms they are recognized to function critically during antero-posterior patterning and the development of the intestinal epithelium. The Cdx homologues, when expressed, modulate a diverse set of processes including proliferation, apoptosis, cell-adhesion, and columnar morphology. They are also necessary for the expression of an increasing number of intestine-specific genes. By targeting these processes and genes, the Cdx homologues promote the appearance of a mature intestinal cell phenotype. In addition to these critical roles during development, accumulating evidence suggests that the Cdx homologues may play significant roles in oncogenesis in the gastrointestinal tract and other tissues. In the colon, several studies suggest the Cdx homologues may act as tumor suppressors. However, ectopic Cdx1 and Cdx2 expression is involved in the development of the precancerous intestinal metaplasia in the stomach and esophagus, and may be a transforming event in one form of acute myelogenous leukemia. This review will explore our current understanding of the roles of the caudal homologues Cdx1 and Cdx2 in intestinal development and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136761     DOI: 10.4161/cbt.3.7.913

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  97 in total

1.  Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Authors:  Daniel Castillo; Sonia Puig; Mar Iglesias; Agustín Seoane; Carme de Bolós; Vicente Munitiz; Pascual Parrilla; Laura Comerma; Richard Poulsom; Kausilia K Krishnadath; Luís Grande; Manuel Pera
Journal:  J Gastrointest Surg       Date:  2011-11-11       Impact factor: 3.452

2.  Lack of reelin modifies the gene expression in the small intestine of mice.

Authors:  P García-Miranda; M D Vázquez-Carretero; G Gutiérrez; M J Peral; A A Ilundáin
Journal:  J Physiol Biochem       Date:  2011-12-08       Impact factor: 4.158

3.  Efficient derivation of pluripotent stem cells from siRNA-mediated Cdx2-deficient mouse embryos.

Authors:  Guangming Wu; Luca Gentile; Jeong Tae Do; Tobias Cantz; Julien Sutter; Katherina Psathaki; Marcos J Araúzo-Bravo; Claudia Ortmeier; Hans R Schöler
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

4.  Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2).

Authors:  Mette Boyd; Morten Hansen; Tine G K Jensen; Anna Perearnau; Anders K Olsen; Lotte L Bram; Mads Bak; Niels Tommerup; Jørgen Olsen; Jesper T Troelsen
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

5.  Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.

Authors:  Arvind Shakya; Jinsuk Kang; Jeffrey Chumley; Matthew A Williams; Dean Tantin
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

Review 6.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2.

Authors:  Michael P Verzi; Hyunjin Shin; H Hansen He; Rita Sulahian; Clifford A Meyer; Robert K Montgomery; James C Fleet; Myles Brown; X Shirley Liu; Ramesh A Shivdasani
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

8.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

9.  EpCAM and gpA33 are markers of Barrett's metaplasia.

Authors:  N A C S Wong; B F Warren; J Piris; N Maynard; R Marshall; W F Bodmer
Journal:  J Clin Pathol       Date:  2006-02-10       Impact factor: 3.411

10.  Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett's esophagus.

Authors:  Yong-Gang Sun; Xing-Wei Wang; Shi-Ming Yang; Gang Zhou; Wei-Qiang Wang; Hong-Bin Wang; Rong-Quan Wang; Dian-Chun Fang
Journal:  J Gastrointest Surg       Date:  2009-05-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.